Georgia Center for Oncology Research and Education; 20 years of service to the State of Georgia; commend
Impact
HR122 serves to honor the contributions of Georgia CORE and acknowledges the organization’s role in addressing a pressing public health issue—cancer, which remains the second leading cause of death in the state. With over 61,000 new cancer diagnoses expected in Georgia in 2023, the resolution underscores the importance of continued investment and innovative partnerships in healthcare to improve cancer treatment and education. This public recognition could help galvanize further support for cancer research initiatives within the state.
Summary
House Resolution 122 (HR122) is a resolution recognizing the Georgia Center for Oncology Research and Education (Georgia CORE) for its 20 years of service to the State of Georgia. The resolution highlights the organization's significant efforts in uniting medical professionals and researchers in the fight against cancer, addressing critical weaknesses in clinical trial availability and research capacity in the state. It celebrates the impact that Georgia CORE has had in increasing cancer survivorship, facilitated partnerships, and enhanced access to cancer care across Georgia.
Contention
While the resolution itself is largely ceremonial and positive in tone, it reflects ongoing discussions regarding how best to tackle healthcare challenges in Georgia, particularly concerning cancer treatment and resources. There may be underlying contention regarding state funding levels for cancer research and how to effectively allocate resources to benefit all citizens equally.